By Mill Chart
Last update: Oct 6, 2025
Aehr Test Systems (NASDAQ:AEHR) reported financial results for the first quarter of fiscal year 2026, delivering a performance that narrowly surpassed analyst expectations on the top line and demonstrated modest profitability on a non-GAAP basis. The market's immediate reaction, however, was decisively negative, with shares falling significantly in after-hours trading.
The semiconductor test equipment supplier reported revenue of $11.0 million for the quarter ended August 29, 2025. While this figure represents a decline from the $13.1 million reported in the same quarter last year, it slightly exceeded the analyst consensus estimate of approximately $11.0 million.
On the bottom line, the company's performance was mixed. Aehr reported a GAAP net loss of $2.1 million, or $0.07 per diluted share. However, on a non-GAAP basis, which excludes items like stock-based compensation and restructuring charges, the company achieved a net income of $0.2 million, or $0.01 per diluted share. This non-GAAP EPS of $0.01 surpassed the analyst estimate, which had projected the company to break even at $0.00 per share.
Key financial metrics from the quarter include:
Despite the earnings beat, the stock was down over 13% in after-market trading. This negative price action suggests investor focus may have shifted from the slight earnings beat to other aspects of the report, such as the year-over-year decline in revenue and the GAAP net loss. The market appears to be weighing the company's current profitability challenges against its future growth narrative.
The press release heavily emphasized the company's strategic positioning within the burgeoning artificial intelligence and data center semiconductor markets. President and CEO Gayn Erickson expressed optimism about the "multi-year market opportunity," pointing to strong momentum for the company's products used in testing and burning-in AI processors.
Significant business developments highlighted include:
Management did not reinstate formal financial guidance for the fiscal year, citing "ongoing tariff-related uncertainty." This lack of formal guidance makes a direct comparison to analyst projections difficult. However, analysts currently estimate the company will generate $62.6 million in revenue for the full 2026 fiscal year. For the upcoming second quarter, the consensus estimates are for revenue of $14.0 million. The company's commentary expressed confidence in "broad-based growth opportunities ahead," but the decision to withhold specific guidance may have contributed to investor caution.
Aehr Test Systems' first quarter presented a paradox of meeting near-term financial expectations while facing a negative market reception. The company successfully exceeded modest profit estimates and is building a compelling narrative around its long-term role in the AI semiconductor supply chain. However, investors seem concerned by the year-over-year revenue contraction and the lack of a concrete financial forecast, choosing to focus on current operational challenges rather than future potential. The company's ability to convert its reported business momentum and a $17.5 million effective backlog into sustained revenue growth in the coming quarters will be critical in reshaping market sentiment.
For a detailed look at future earnings estimates and historical performance, you can review the earnings and estimates data for AEHR.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, nor does it recommend buying or selling any securities.
31.65
+0.63 (+2.03%)
Find more stocks in the Stock Screener